مباشر

Endpoints NewsRA, Forbion and Sanofi Ventures appear to back new eye drug from Korea Endpoints NewsNovocure’s electric fields therapy fails key glioblastoma study PharmaVoiceAs M&A rebounds, here’s how pharmas can prepare to seal a deal FierceBiotechKardigan buttons up $400M upsized IPO to power heart drugs toward phase 3 FierceBiotechNovocure device fails to improve brain cancer patients’ survival in phase 3 test FierceBiotechNortiva purrs into action with long-acting Lynx platform salvaged from Langer startup Endpoints NewsInnoviva revives Lyndra's long-acting oral drug platform FierceBiotechBiogen inks $1B RayThera buyout to bag preclinical immunology assets Endpoints NewsModerna adds commercial chief, expands Stephen Hoge's role; Reunion Neuroscience CEO departs Endpoints NewsEli Lilly's TuneLab hits 100 members, adding Chai's AI models CellChloroplast sunscreening by protein condensates confers high-light tolerance PharmaVoiceA new Westlake-backed biotech takes aim at migraines

Endpoints News ١٨ يونيو ٢٠٢٦

Eli Lilly's TuneLab hits 100 members, adding Chai's AI models

The leader behind TuneLab, Eli Lilly's first-of-its-kind AI initiative, had no idea what to expect when it launched. Lilly was trying something new by effective...

The leader behind TuneLab, Eli Lilly's first-of-its-kind AI initiative, had no idea what to expect when it launched. Lilly was trying something new by effectively offering biotechs free access to some of ...